Polyclinique du Parc, 31078 Toulouse, France Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01237483
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Védrines, Philippe, M.D.

Active Ingredients

Drugs in Phase 4 Trials (1)

azathioprine (imuran) (1 trial)

Drugs in Phase 2 Trials (1)

cetuximab (erbitux) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Head and Neck Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2